A novel human multiple myeloma cell line with genetic abnormality of 1q21 gains only and CKS1B overexpression
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
![Cancers | Free Full-Text | The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis | HTML Cancers | Free Full-Text | The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis | HTML](https://www.mdpi.com/cancers/cancers-12-02341/article_deploy/html/images/cancers-12-02341-g006.png)
Cancers | Free Full-Text | The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis | HTML
![Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC](https://europepmc.org/articles/PMC3479604/bin/pnas.1212759109fig02.jpg)
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC
![Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS](https://www.pnas.org/cms/10.1073/pnas.1212759109/asset/fc06695e-20a9-45e6-8bc1-014ad0fccf3d/assets/graphic/pnas.1212759109fig03.jpeg)
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
![Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120699153-gr1.jpg)
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
![WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents](https://patentimages.storage.googleapis.com/1d/b1/59/daec0bdad154d0/PCTCN2014001097-appb-300014.png)
WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents
![The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients - Experimental Hematology The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients - Experimental Hematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5b923915-3199-4363-90d2-ffc2ad1f21cf/gr1_lrg.jpg)